Product
Supplier
Encyclopedia
Inquiry
Febuxostat 98% buy - large image1
Febuxostat 98% buy - image1

Febuxostat 98%

GMP 24 Inquiries

Unit Price: Get Latest Price
CAS No.:

144060-53-7

Grade:

Pharmaceutical Grade

Content:

98%

Port:

Shanghai

Packaging:

25kg/drum

Price valid (until):

2024-12-31

Company Type:
Manufactory
Location:
China
Qualification:
Main Products:

APIs,Veterinary,Cosmetic Ingredients,Peptides,intermediates,food ingredients

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    Febuxostat, a selective xanthine oxidase inhibitor, was launched for the chronic management of hyperuricemia in patients with gout. Hyperuricemia is defined as a serum uric acid concentration exceeding the limit of solubility. It predisposes affected persons to gout, a disease characterized by the formation of crystals of monosodium urate or uric acid from supersaturated fluids in joints and other tissues. Crystal deposition is asymptomatic, but it is revealed by bouts of joint inflammation. If left untreated, further crystals accumulate in joints and can form deposits known as tophi. A major aim in gout management is the long-term reduction of serum uric acid concentrations below saturation levels, as this results in crystal dissolution and eventual disappearance.

    Items Specifications






    Certificates

    Basic Info
    Product Name:

    Febuxostat

    Other Name:

    5-Thiazolecarboxylic acid,2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methyl-;2-[3-Cyano-4-(2-methylpropoxy)phenyl]-4-methyl-5-thiazolecarboxylic acid;TEI 6720;TMX 67;2-(3-Cyano-4-isobutyloxyphenyl)-4-methyl-5-thiazolecarboxylic acid;Febuxostat;FBX;Uloric;Feburic;Febugood;Febutaz;Zurig;2-(3-Cyano-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylic acid;2-[3-Cyano-4-(2-methylpropoxy)phenyl]-4-methyl-1,3-thiazole-5-carboxylic acid;Adenuric

    CAS No.:

    144060-53-7

    Molecular Formula:

    C16H16N2O3S

    InChIKeys:

    InChIKey=BQSJTQLCZDPROO-UHFFFAOYSA-N

    Molecular Weight:

    316.37500

    Exact Mass:

    316.37

    UNII:

    101V0R1N2E

    NSC Number:

    758874

    DSSTox ID:

    DTXSID8048650

    NCI Thesaurus Code:

    C65629

    ATC Code:

    M04AA03|M - Musculo-skeletal system

    HScode:

    2934100090

    Characteristics
    PSA:

    111.45000

    XLogP3:

    3.9

    Appearance:

    Crystalline Solid

    Density:

    1.31 g/cm3

    Melting Point:

    238-239ºC

    Boiling Point:

    536.6ºC at 760 mmHg

    Flash Point:

    278.3ºC

    Refractive Index:

    1.605

    Vapor Pressure:

    2.41E-12mmHg at 25°C

    Collision Cross Section:

    180.6 Ų [M+H]+ [CCS Type: TW, Method: calibrated with polyalanine and drug standards]

    Hazard Identification

    Classification of the substance or mixture

    Acute toxicity - Category 4, Oral

    GHS label elements, including precautionary statements

    Pictogram(s)
    Signal word

    Warning

    Hazard statement(s)

    H302 Harmful if swallowed

    Precautionary statement(s)
    Prevention

    P264 Wash ... thoroughly after handling.

    P270 Do not eat, drink or smoke when using this product.

    Response

    P301+P317 IF SWALLOWED: Get medical help.

    P330 Rinse mouth.

    Storage

    none

    Disposal

    P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Manufactory

    Main Products:

    APIs,Veterinary,Cosmetic Ingredients,Peptides,intermediates,food ingredients

    Location:

    T2-805,European and American Financial City,Cangqian Street,Yuhang District,Hangzhou,China.(zip code:311121)

    Payment Terms:

    TT against copy of documents,D/P,L/C,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    20

    Total Annual Revenue:

    $10 million-$25 million

    Total Employees:

    11-50

    Year of Establishment:

    2009

    Hangzhou Holypharm Biotech Co., Ltd was founded in Hangzhou in 2006. Over the decades, Holypharm has maintained sound development and rapid global expansion. Based on China and looking at the world, the Holypharm has become a leading professional health industry chain service group in China.

     

    Holypharm supplies different kinds of products, covering the whole field of health industry, including human APIs, veterinary APIs, intermediates, food additives, natural nutrition ingredients, feed additives, cosmetic additives, , medical devices, etc. Based on the deep strategic cooperation with Brightgene Pharmaceutical Company, and integrated production advantages, Holypharm's marketing network has spread over more than 40 countries and regions on five continents, providing professional service for global customers.

     

    With a commitment to quality and customer satisfaction, Holypharm has become a trusted name in the industry. Our strong product line includes like a range of high-quality tripeptide copper, (±)-Lipoic acid in cosmetics, Sameglutide Tirzepatide in the field of metabolism which are available at competitive prices. Holypharm has established itself as a reliable supplier of chemical products on the echemi.com.

     

    In the future, Holypharm will expand its business in the CDMO and OEM industry, connect the investment, R&D and production, and gradually become a integrated enterprise. Holypharm will stay true to the mission of serving the global health industry and helping create a win-win situation.


  • Inquiry History
    24 Inquiries
    Country Product Purchase Quantity Date Posted
    India

    Febuxostat

    1.00 KG Jan 19, 2024
    India

    Febuxostat

    5.00 KG Jan 22, 2024
    India

    FEBUXOSTAT USP

    40.00 KG Oct 16, 2025
    Philippines

    Febuxostat

    1 KG Jun 2, 2026
    India

    Febuxostat

    1.00 KG May 9, 2026
    India

    Febuxostat 

    1.00 KG Apr 21, 2026
    India

    Febuxostat

    2 MT May 17, 2024
    India

    Febuxostat

    1.00 KG Jun 4, 2026
    India

    Febuxostat

    1.00 KG May 27, 2026
    India

    Febuxostat

    100.00 KG Apr 23, 2026
    Pakistan

    Febuxostat

    300.00 KG Feb 24, 2026
    Pakistan

    Febuxostat

    50 KG Jan 12, 2026
    India

    FEBUXOSTAT 

    25.00 KG Mar 25, 2025
    India

    Febuxostat

    1.00 KG Mar 15, 2024
    Pakistan

    Febuxostat

    300.00 KG Apr 20, 2026
    Pakistan

    Febuxostat

    300.00 KG Mar 16, 2026
    India

    Febuxostat

    500.00 KG Nov 28, 2025
    India

    Febuxostat

    30.00 KG Nov 26, 2025
    India

    Febuxostat

    1.00 MT Feb 8, 2025
    India

    Linagliptin

    5.00 KG Jan 22, 2024
    • 1
    • 2
    • Go to Page Go
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.